Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Annals of the Rheumatic Diseases 2006;65:816-819; doi:10.1136/ard.2005.042473
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kling, A
Right arrow Articles by Mjörndal, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kling, A
Right arrow Articles by Mjörndal, T
Related Collections
Right arrow Genetics
Right arrow Rheumatoid Arthritis
Right arrow Chemical Pathology

CONCISE REPORT

Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis

A Kling 1, S Rantapää-Dahlqvist 2, H Stenlund 3, T Mjörndal 1

1 Department of Pharmacology and Clinical Neurosciences, Division of Clinical Pharmacology, Umeå University Hospital, Umeå, Sweden
2 Department of Rheumatology, Umeå University Hospital
3 Department of Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University

Correspondence to:
Correspondence to:
Dr Anders Kling
Division of Clinical Pharmacology, Umeå University Hospital, S-901 85 Umeå, Sweden; anders.kling{at}pharm.umu.se


ABSTRACT
Background: Animal studies have indicated that 5-HT2A receptors could play a role in arthritic diseases.

Objective: To analyse the binding properties of 5-HT2A receptors in patients with rheumatoid arthritis.

Methods: Using a radioactive binding assay, 43 patients with rheumatoid arthritis were compared with 49 sex and age matched controls for density and affinity (measured as Bmax and Kd) of 5-HT2A serotonin receptors. Genotyping, using polymerase chain reaction, was undertaken to exclude the possibility that differences in the genetic polymorphism T102C for the 5-HT2A receptor determine differences in receptor density.

Results: Mean of Bmax of 5-HT2A receptors in rheumatoid patients was significantly lower than in controls, at 45.3 v 57.4 fmol/mg protein (p = 0.004), but there was no significant difference in Kd. The T102C receptor polymorphism genotypes showed a skewed distribution between the two groups. Even when adjusted for this, there was a significant difference in Bmax between the groups.

Conclusions: The density of 5-HT2A serotonin receptors in patients with rheumatoid arthritis is markedly reduced. This could either reflect a difference involved in the susceptibility to the disease or be a secondary effect of the disease.


Abbreviations: AA, adjuvant induced arthritis; [3H]LSD, [3H]-lysergic acid diethylamide; 5-HT, 5-hydroxytryptamine (serotonin)

Keywords: rheumatoid arthritis; serotonin; serotonin receptor 5-HT2A







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism